How to Control Impurities during API drug manufacturing

Posted: February 19, 2018

Author:
Tags: API Manufacturing | Impurities | Video
API Manufacturing and Pharmaceutical Manufacturing

Dr. Rajesh Shukla, Vice President Research and Development at PCI Synthesis Talks about Controlling Impurities during API drug manufacturing.

Related posts:

Dealing with the Unexpected in API Development
Three Things to Know About API Development for Phase 2 Clinical Trials
Dealing with Tariffs and Other Uncertainties
How to Select a CMO
The Double-Edged Sword of Pharma Industry Consolidation